| Patents for C07J 43 - Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,516) |
|---|
| 03/05/2014 | EP2703408A1 Method for purifying rocuronium bromide |
| 02/19/2014 | CN103588847A Preparation method for rocuronium bromide intermediate |
| 02/12/2014 | CN103570793A Bile acid type compound, intermediate, preparation method and application of bile acid type compound |
| 02/12/2014 | CN103570792A Bufalin derivative as well as preparation method, pharmaceutical composition and application thereof |
| 02/12/2014 | CN103570791A Novel synthesis method of Abiraterone acetate |
| 02/12/2014 | CN103570790A Protopanoxadiol derivative, preparation method of derivative, composition containing derivative and application of composition |
| 02/05/2014 | CN103554210A Sterides 5 alpha-reductase inhibitor, as well as preparation method and medical application thereof |
| 01/30/2014 | WO2014016830A1 Process and intermediates for the preparation of abiraterone acetate |
| 01/23/2014 | US20140024631 Steroids as Agonists for FXR |
| 01/16/2014 | WO2014009274A1 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments |
| 01/16/2014 | US20140018337 Steroids Having 7-Oxygen and 17-Heteroaryl Substitution-3 |
| 01/16/2014 | US20140018336 Steroids Having 7-Oxygen and 17-Heteroaryl Substitution-2 |
| 01/16/2014 | US20140018312 Steroid alkaloids and uses thereof as antimicrobial agents against electron transport-deficient microbes and as potentiators for antimicrobial agents against pathogenic bacteria |
| 01/09/2014 | US20140011992 Synthesis of abiraterone and related compounds |
| 01/09/2014 | US20140011786 Synthesis and use of anti-tumor drug lqc-y |
| 01/08/2014 | CN101921597B Liquid crystal alignment agent and liquid crystal display element |
| 01/02/2014 | US20140005156 Aminoalkylsterol compounds with antitumoral and neuroprotective activity |
| 01/02/2014 | US20140005132 Contraceptive agents |
| 12/19/2013 | US20130336996 Novel compositions of tlr7 and/or tlr8 agonists conjugated to lipids |
| 12/18/2013 | CN103450313A Preparation method of abiraterone acetate |
| 12/18/2013 | CN103450312A New crystal form of vecuronium bromide, and preparation method and use thereof |
| 12/18/2013 | CN103450311A New crystal form of vecuronium bromide, and preparation method and use thereof |
| 12/17/2013 | CA2636040C Metabolites of wortmannin analogs and methods of using the same |
| 12/12/2013 | US20130331578 Novel iminosugars and their applications |
| 12/11/2013 | CN103435675A Method for refining steroid muscle relaxant |
| 12/11/2013 | CN103435674A Preparation method of high-purity high-stability rocuronium bromide |
| 12/11/2013 | CN102603850B Vecuronium bromide compound and production method thereof |
| 12/04/2013 | EP2669293A1 Preparation method of rocuronium |
| 12/04/2013 | CN103421073A Preparation method of Abiraterone |
| 11/19/2013 | US8586569 Betulonic and betulinic acid derivatives |
| 11/19/2013 | CA2649173C Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders |
| 11/14/2013 | US20130303753 Preparation method of rocuronium |
| 11/14/2013 | US20130303500 Compounds and methods for treating neoplasia |
| 11/13/2013 | CN103387597A Preparation method of abiraterone acetic ester |
| 11/06/2013 | EP2660241A2 C-17-heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21 |
| 11/06/2013 | CN103382213A 17-(2', 5'-disubstituted oxazolyl)-androstane-4, 16-diene-3-ketone, and preparation method and applications thereof |
| 10/31/2013 | WO2013160810A2 Novel betulinic acid derivatives as hiv inhibitors |
| 10/31/2013 | WO2013159225A1 Process for preparation of 17-substituted steroids |
| 10/30/2013 | CN102558276B Non-sizing pipecuronium and preparation method and purpose thereof |
| 10/29/2013 | US8569275 Steroids having 7-oxgen and 17-heteroaryl substitution |
| 10/23/2013 | EP2651916A2 C-17-heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21 |
| 10/23/2013 | CN103360458A Synthesis method of abiraterone |
| 10/09/2013 | CN103343013A Ionic liquid crystal compound containing imidazole and cholesteric ester groups and preparation method thereof |
| 10/01/2013 | CA2609726C 17.beta.-hsd1 and sts inhibitors |
| 09/26/2013 | US20130252930 Cyp11b, cyp17, and/or cyp21 inhibitors |
| 09/19/2013 | US20130245253 Conjugated Neuroactive Steroid Compositions And Methods Of Use |
| 09/17/2013 | US8536160 Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders |
| 09/17/2013 | CA2610475C Derivative prodrugs of ethinyl estradiol |
| 09/04/2013 | CN103282358A Cyp11b, cyp17, and/or cyp21 inhibitors |
| 09/04/2013 | CN103275161A 3-hydroxyl cholest-6-keto aromatic aldehyde azine steroidal compound, synthetic method of steroidal compound and application of steroidal compound in preparation of anti-tumour drug |
| 09/04/2013 | CN102161688B Cholesterol-structure-fragment-containing biocompatible synthesis liposomes as well as preparation method and application thereof |
| 09/03/2013 | US8524694 Aminoalkylsterol compounds with antitumoral and neuroprotective activity |
| 08/21/2013 | CN103254265A Abiraterone acetate trifluoroacetate, and preparation method and application thereof |
| 08/21/2013 | CN103254264A Pregnenolone aromatic aldehydes azine steroid compound and synthetic method thereof as well as application of compound in preparation of antitumor medicines |
| 08/15/2013 | US20130210785 Progesterone analogs and uses related thereto |
| 08/14/2013 | CN103242411A Preparation method and application of novel cholalic acid-porphyrin conjugate |
| 08/14/2013 | CN103242410A Preparation method of abiraterone acetate |
| 08/14/2013 | CN103242406A Dehydroepiandrosterone aromatic aldehyde azine steroidal compound and synthetic method thereof as well as application thereof in preparation of anti-tumor drugs |
| 08/13/2013 | CA2599953C Novel c-17-heteroaryl steroidal cyp17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity |
| 07/24/2013 | CN101863948B High-purity (2 beta, 3 alpha, 5 alpha, 16 beta, 17 beta)-2-(4-morpholinyl)-16-(1-pyrrolidinyl)-androstane-3,17-diol or composition thereof and preparation method thereof |
| 07/10/2013 | CN103193849A Preparation method of high-purity abiraterone acetate |
| 06/26/2013 | EP2607371A1 Processes for the preparation of abiraterone and related compouds |
| 06/26/2013 | CN103172690A Methods for preparing abiraterone acetate and intermediate thereof |
| 06/20/2013 | WO2013030410A3 Synthesis of abiraterone and related compounds |
| 06/20/2013 | US20130156705 Bivalent multifunctional ligands targeting a[beta] oligomers as treatment for alzheimer's disease |
| 06/12/2013 | CN103154014A Modified nucleosides and oligomeric compounds prepared therefrom |
| 05/30/2013 | US20130137648 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 05/16/2013 | US20130123225 Inhibition of bacterial biofilms with aryl carbamates |
| 05/16/2013 | US20130123224 Certain chemical entities, compositions, and methods |
| 05/16/2013 | CA2854631A1 Indolealkylamino-withasteroid conjugates and method of use |
| 05/15/2013 | CN103102381A Synthesis method of novel abiraterone |
| 05/15/2013 | CN102336801B Abiraterone acetate polymorphic substance and pharmaceutical composition |
| 05/08/2013 | CN103087137A Glucocorticoid with sulfoalkyl group at position 21 |
| 05/07/2013 | US8435973 17-beta HSD1 and STS inhibitors |
| 05/07/2013 | CA2576922C Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether |
| 04/25/2013 | WO2013057148A1 ACID ADDITION SALTS OF 5α-HYDROXY-6β-[2-(1H-IMIDAZOL-4-YL)ETHYLAMINO]CHOLESTAN-3β-OL |
| 04/25/2013 | CA2852622A1 Acid addition salts of 5.alpha.-hydroxy-6.beta.-[2-(1h-imidazol-4-yl)ethylamino]cholestan-3.beta.-ol |
| 04/24/2013 | CN103059091A Method for preparing abiraterone acetate without heavy-metal residue |
| 04/24/2013 | CN103059090A Abiraterone acetate oxalate and purification method of abiraterone acetate |
| 04/18/2013 | WO2013056181A1 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof |
| 04/18/2013 | WO2013053691A1 Process for preparing 17-substituted steroids |
| 04/18/2013 | CA2852057A1 3,3-disubstituted 19-nor pregnane compounds, compositions, and uses thereof |
| 04/18/2013 | CA2851330A1 Process for preparing 17-substituted steroids |
| 04/17/2013 | CN102344479B Preparation method of quaternary ammonium salts of methyl ammonium bromide |
| 04/11/2013 | US20130090468 Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether |
| 04/10/2013 | CN103028115A Programmed-drug-release azobenzene derivative carrier, and preparation method and application thereof |
| 04/10/2013 | CN101775062B Cationic lipid containing carbamate and cyclic polyamine, transgenic vector and preparation method |
| 04/04/2013 | WO2013045407A1 Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and use thereof for production of medicaments |
| 04/04/2013 | DE102011083725A1 Estra-1,3,5(10),16-tetraen-3-carboxamid-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln Estra-1,3,5 (10), 16-tetraene-3-carboxamide derivatives, process for their preparation, pharmaceutical compositions containing them, and their use for the preparation of medicaments |
| 04/04/2013 | CA2850047A1 Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and use thereof for production of medicaments |
| 03/21/2013 | US20130072464 Progesterone receptor antagonists |
| 03/20/2013 | CN102030797B Technetium-labeled estradiol derivative and reference compound thereof, and preparation method, application and intermediate thereof |
| 03/07/2013 | WO2013030410A2 Synthesis of abiraterone and related compounds |
| 03/06/2013 | CN102952168A Estrogen derivative used as vasoinhibitor, as well as preparation method and medical application thereof |
| 03/05/2013 | US8389714 Process for the preparation of 17-0-vinyl-triflates as intermediates |
| 02/19/2013 | US8377916 Steroids as agonists for FXR |
| 02/14/2013 | CA2843837A1 Methods and compositions for improving sperm functionality |
| 02/13/2013 | CN102924556A (20S, 24R)-ocotillol type ginsenoside derivative having antibacterial activity and preparation method and application thereof |
| 02/13/2013 | CN101624414B Nitrate medicament for inhibiting angiogenesis |
| 02/07/2013 | US20130035304 Small molecules for the modulation of mcl-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders |